1. Home
  2. STVN vs CFLT Comparison

STVN vs CFLT Comparison

Compare STVN & CFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • CFLT
  • Stock Information
  • Founded
  • STVN 1949
  • CFLT 2014
  • Country
  • STVN Italy
  • CFLT United States
  • Employees
  • STVN N/A
  • CFLT N/A
  • Industry
  • STVN Containers/Packaging
  • CFLT EDP Services
  • Sector
  • STVN Consumer Discretionary
  • CFLT Technology
  • Exchange
  • STVN Nasdaq
  • CFLT Nasdaq
  • Market Cap
  • STVN 6.6B
  • CFLT 7.8B
  • IPO Year
  • STVN 2021
  • CFLT 2021
  • Fundamental
  • Price
  • STVN $24.59
  • CFLT $26.01
  • Analyst Decision
  • STVN Buy
  • CFLT Buy
  • Analyst Count
  • STVN 6
  • CFLT 30
  • Target Price
  • STVN $25.08
  • CFLT $31.00
  • AVG Volume (30 Days)
  • STVN 337.6K
  • CFLT 5.3M
  • Earning Date
  • STVN 08-05-2025
  • CFLT 07-30-2025
  • Dividend Yield
  • STVN 0.26%
  • CFLT N/A
  • EPS Growth
  • STVN N/A
  • CFLT N/A
  • EPS
  • STVN 0.50
  • CFLT N/A
  • Revenue
  • STVN $1,215,562,040.00
  • CFLT $1,017,525,000.00
  • Revenue This Year
  • STVN $8.69
  • CFLT $21.52
  • Revenue Next Year
  • STVN $10.67
  • CFLT $18.27
  • P/E Ratio
  • STVN $49.56
  • CFLT N/A
  • Revenue Growth
  • STVN 3.81
  • CFLT 24.11
  • 52 Week Low
  • STVN $17.12
  • CFLT $17.79
  • 52 Week High
  • STVN $25.88
  • CFLT $37.90
  • Technical
  • Relative Strength Index (RSI)
  • STVN 56.81
  • CFLT 70.16
  • Support Level
  • STVN $24.06
  • CFLT $23.82
  • Resistance Level
  • STVN $25.36
  • CFLT $25.08
  • Average True Range (ATR)
  • STVN 1.10
  • CFLT 0.91
  • MACD
  • STVN 0.01
  • CFLT 0.18
  • Stochastic Oscillator
  • STVN 67.06
  • CFLT 90.00

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About CFLT Confluent Inc.

Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.

Share on Social Networks: